April 5, 2019
Mallinckrodt study shows ECP improves survival in therapy by 30% in lung transplant patients with BOS
Mallinckrodt’s retrospective study has shown the effectiveness of Extracorporeal Photopheresis (ECP), as an adjunct to local standard therapy, in lung transplant recipients with Bronchiolitis Obliterans Syndrome (BOS).
